Every life sciences company wants to be AI-ready. But very few have the data infrastructure to support it. The typical pharma data landscape is a patchwork of legacy systems, on-premise data warehouses, siloed departmental databases, and vendor-specific analytics tools – none of which were designed for the demands of modern AI. Platform modernization is not […]
Cell and gene therapies represent the frontier of medicine – personalized, potentially curative treatments that are manufactured for a single patient. But the operational complexity of delivering these therapies is staggering. From patient identification to apheresis, from manufacturing to quality release, from logistics to infusion – every step involves multiple stakeholders, strict timelines, and zero […]
Drug launches are the highest-stakes moment in a pharma company’s commercial lifecycle. Get it right, and you establish market position for a decade. Get it wrong, and you spend the next five years playing catch-up – at three to five times the cost of getting it right the first time. Yet most companies still approach […]
